Details:

Corporate Authors:
Centers for Disease Control and Prevention (U.S.) ;
Description:
Wednesday, May 27, 2009, 11:30 EDT (11:30 AM EDT) CDCHAN-00293-2009-05-27-UPD-N As a reminder to clinicians, this Health Update summarizes existing CDC guidance issued on May 6, 2009 on the use of antiviral drugs in novel H1N1 patients and their close contacts. CDC recommends that influenza antiviral treatment be given to all hospitalized patients with confirmed, probable, or suspected novel influenza A (H1N1) and any patient with confirmed, probable or suspected novel influenza A (H1N1) who is at higher risk for seasonal influenza complications. All hospitalized patients should be carefully monitored and treated with antiviral medications as soon as possible after admission, including patients who seek treatment more than 48 hours after onset of symptoms. The drugs recommended for treatment are either oseltamivir or zanamivir. The novel H1N1 viruses are resistant to amantadine and rimantadine.
Subject:
[+]
Antiviral Agents
Influenza, Human/drug Therapy
Influenza, Human/prevention & Control
Influenza A Virus, H1N1 Subtype
Oseltamivir
Zanamivir

Series:
HAN ; 293;
Document Type:
HAN Health Update ;
Place as Subject:
United States ;
Collection(s):
Health Alert Network (HAN)
Main Document Checksum:
[+]
urn:sha256:92698bbd49dd059020b0ff881e9f60b08e9d05450246dfe9c0d8e96315d791b5
File Type:

Supporting Files

• No Additional Files

More +